Ritalincel
⛆⛆⛆⛆
★★★★★
- Joined
- Nov 25, 2017
- Posts
- 35,797
http://www.dailymail.co.uk/health/a...tate-cancer-patients-life-extending-drug.html
Fury as health watchdogs deny 7,000 prostate cancer patients a life-extending drug that doubles their survival chances because it is not deemed 'value for money'
- Abiraterone is hailed as one the greatest achievements in the NHS's history
- Costing £2,700 a month, it can double average survival times, experts claim
- But it has been rejected by Nice, in draft guidance, due to a lack of evidence
- The body also said it couldn't guarantee that the drug offered 'value for money